BRPI0922714A2 - composto, processo para preparar um compsoto, medicamento, uso de um composto, e, composição farmacêutica - Google Patents

composto, processo para preparar um compsoto, medicamento, uso de um composto, e, composição farmacêutica

Info

Publication number
BRPI0922714A2
BRPI0922714A2 BRPI0922714A BRPI0922714A BRPI0922714A2 BR PI0922714 A2 BRPI0922714 A2 BR PI0922714A2 BR PI0922714 A BRPI0922714 A BR PI0922714A BR PI0922714 A BRPI0922714 A BR PI0922714A BR PI0922714 A2 BRPI0922714 A2 BR PI0922714A2
Authority
BR
Brazil
Prior art keywords
compound
drug
preparing
pharmaceutical composition
pharmaceutical
Prior art date
Application number
BRPI0922714A
Other languages
English (en)
Inventor
Elmar Wegener
Josephus H M Lange
Konrad F Koehler
Michael Mlinaric
Pieter Smid
Sara Nunez-Garcia
Original Assignee
Abbott Healthcare Products Bv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Abbott Healthcare Products Bv filed Critical Abbott Healthcare Products Bv
Publication of BRPI0922714A2 publication Critical patent/BRPI0922714A2/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D498/10—Spiro-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Rheumatology (AREA)
  • Obesity (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Pain & Pain Management (AREA)
  • Transplantation (AREA)
  • Child & Adolescent Psychology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Dermatology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
BRPI0922714A 2008-12-12 2009-12-10 composto, processo para preparar um compsoto, medicamento, uso de um composto, e, composição farmacêutica BRPI0922714A2 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US12191308P 2008-12-12 2008-12-12
EP08171421 2008-12-12
PCT/EP2009/066836 WO2010066840A1 (en) 2008-12-12 2009-12-10 SPIRO AZEPANE-OXAZOLIDINONES AS Kv1.3 POTASSIUM CHANNEL BLOCKERS

Publications (1)

Publication Number Publication Date
BRPI0922714A2 true BRPI0922714A2 (pt) 2016-01-05

Family

ID=40513443

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0922714A BRPI0922714A2 (pt) 2008-12-12 2009-12-10 composto, processo para preparar um compsoto, medicamento, uso de um composto, e, composição farmacêutica

Country Status (20)

Country Link
US (1) US8575148B2 (pt)
EP (1) EP2376501A1 (pt)
JP (1) JP2012511546A (pt)
KR (1) KR20110110165A (pt)
CN (1) CN102333782A (pt)
AR (1) AR074558A1 (pt)
AU (1) AU2009324358A1 (pt)
BR (1) BRPI0922714A2 (pt)
CA (1) CA2743557A1 (pt)
CO (1) CO6390036A2 (pt)
CR (1) CR20110302A (pt)
DO (1) DOP2011000164A (pt)
EA (1) EA201170801A1 (pt)
EC (1) ECSP11011118A (pt)
IL (1) IL212948A0 (pt)
MX (1) MX2011006221A (pt)
PE (1) PE20110772A1 (pt)
TW (1) TW201026708A (pt)
WO (1) WO2010066840A1 (pt)
ZA (1) ZA201104041B (pt)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2013052507A1 (en) * 2011-10-03 2013-04-11 The Regents Of The University Of California TREATMENT OF OBESITY AND OBESITY-RELATED DISORDERS BY PHARMACOLOGICAL TARGETING OF Kv1.3 POTASSIUM CHANNELS
UA114649C2 (uk) 2012-10-29 2017-07-10 Ф. Хоффманн-Ля Рош Аг Похідні 3,4-дизаміщеного оксазолідинону та їх застосування як інгібіторів кальцій-активованих калієвих каналів
TWI701249B (zh) 2015-03-13 2020-08-11 德商４Ｓｃ製藥公司 Ｋv１.３抑制劑及其醫學應用
TWI698438B (zh) 2015-03-13 2020-07-11 德商４Ｓｃ製藥公司 Ｋv１.３抑制劑及其醫學應用
CN109053751A (zh) * 2018-08-30 2018-12-21 成都海博锐药业有限公司 具有螺环结构的fxr调节剂
WO2020252130A1 (en) * 2019-06-12 2020-12-17 Lieber Institute, Inc. Kv11.1-3.1 inhibiting methods and compositions
IL291867A (en) * 2019-10-07 2022-06-01 De Shaw Res Llc Heterocyclic aryl compounds as Shaker kv1.3 potassium channel blockers
US20220411367A1 (en) * 2019-10-07 2022-12-29 D. E. Shaw Research, Llc Arylmethylene heterocyclic compounds as kv1.3 potassium shaker channel blockers
CN114828963A (zh) * 2019-10-07 2022-07-29 D·E·萧尔研究有限责任公司 作为Kv1.3钾SHAKER通道阻滞剂的芳基杂二环化合物
CN111574537B (zh) * 2020-05-20 2022-11-15 成都药明康德新药开发有限公司 叔丁基-8-氧杂-3,11-二氮杂螺[5.6]十二烷-3-甲酸基酯的合成方法
EP4415706A4 (en) * 2021-10-13 2025-08-27 Vanqua Bio Inc SMALL MOLECULE MODULATORS OF GLUCOCEREBROSIDASE ACTIVITY AND THEIR USES

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6303637B1 (en) 1998-10-30 2001-10-16 Merck & Co., Inc. Heterocyclic potassium channel inhibitors

Also Published As

Publication number Publication date
US20110237569A1 (en) 2011-09-29
CO6390036A2 (es) 2012-02-29
IL212948A0 (en) 2011-07-31
AU2009324358A1 (en) 2011-06-23
ZA201104041B (en) 2012-11-28
CR20110302A (es) 2011-10-27
TW201026708A (en) 2010-07-16
EP2376501A1 (en) 2011-10-19
CN102333782A (zh) 2012-01-25
EA201170801A1 (ru) 2011-12-30
DOP2011000164A (es) 2011-06-30
ECSP11011118A (es) 2011-07-29
KR20110110165A (ko) 2011-10-06
AR074558A1 (es) 2011-01-26
PE20110772A1 (es) 2011-10-19
WO2010066840A1 (en) 2010-06-17
JP2012511546A (ja) 2012-05-24
CA2743557A1 (en) 2010-06-17
MX2011006221A (es) 2011-06-28
US8575148B2 (en) 2013-11-05

Similar Documents

Publication Publication Date Title
BRPI0906475A2 (pt) Compostos, processso para a preparação de um composto, composição farmacêutica e uso de um composto
BRPI1006162A2 (pt) "composto,processo para preparar um composto,formulação farmacêutica,e uso de um composto".
BRPI0818533A2 (pt) composto, composição farmacêutica, e, processo para a preparação de um composto
BRPI0922714A2 (pt) composto, processo para preparar um compsoto, medicamento, uso de um composto, e, composição farmacêutica
BRPI0816331A2 (pt) Composto, uso de um composto, composição farmacêutica, e, processo para preparar um composto.
BRPI0914927A2 (pt) composto, composição farmacêutica, métodos para inibir a função de fak e de tratamento de um câncer, uso de um composto, e, processo para preparar um composto
BRPI0909691A2 (pt) Composto, método para preparar um composto, e, composição farmacêutica
BRPI0908738A2 (pt) composto, medicamento, uso de um composto, e, processo para preparar os compostos
BRPI0912348A2 (pt) composto de 3-aminocarbazol, composição farmacêutica, método para preparar um composto de 3-aminocarbazol, uso de um composto de 3-aminocarbazol, e, método para tratar ou prevenir doenças
BRPI0919942A2 (pt) Composto, composição farmacêutica, e, uso de um composto
BRPI0907562A2 (pt) composto, composição farmacêutica, e, uso de um composto
BRPI0921375A2 (pt) composto, composição farmacêutica, e, uso de um composto
BR112012016201A2 (pt) ''composto, processo para a preparação de um composto, composição farmacêutica e uso de um composto''
BRPI0817423A2 (pt) Processos para a preparação de um composto, para a preparação de uma formulação farmacêutica, e para a preparação de um intermediário de um composto, e, composto
BRPI0908252A2 (pt) Processo para preparar um composto, e, uso de um composto
BRPI0917579A2 (pt) composto, composição farmacêutica, métodos, e, uso de um composto
BRPI0822946A2 (pt) Derivado de carboxiamida, processo para preparação de derivado de carboxiamida, composição farmacêutica e uso do derivado de carboxiamida
BR112012008485A2 (pt) composto, formulação farmacêutica, uso de um composto, processo para a fabricação do composto de formula e compostos, processos, formulações e usos
BRPI0921879A2 (pt) composto, composição farmacêutica , e, uso de um composto
BR112013028959A2 (pt) composto, processo para o preparo de um composto, combinação de um composto, composição farmacêutica, uso de um composto, dispositivo e kit
BRPI0815493A2 (pt) Composto, uso de um composto, composição faramcêutica, método para a terapia de dor, e, processo para preparar um composto.
BRPI0811275A2 (pt) Composto, processo para a preparação do mesmo, composição farmacêutica, uso de composto, e, método para tratar doença
BR112013008008A2 (pt) composto, composição farmacêutica e processo para preparar um composto
BRPI0817889A2 (pt) Composição farmacêutica, composto misto de metal para uso como um medicamento, uso de um composto misto de metal, e, processo para a produção de um composto misto de metal esgotado de magnésio
BRPI0814821A2 (pt) Composto, composição farmacêutica, e, processo para preparar um composto

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE AS 4A, 5A E 6A ANUIDADES.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2376 DE 19-07-2016 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.